Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Thiry

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|July 10, 2009
Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in BelgiumIrina Cleemput, Nancy Thiry
Vaccine|January 9, 2007
Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006)Philippe Beutels, Nancy Thiry, Pierre Van Damme
Health Policy (Amsterdam, Netherlands)|May 22, 2012
Calculating an intervention's (cost-)effectiveness for the real-world target population: the potential of combining strengths of both RCTs and observational dataMattias Neyt, Irina Cleemput, Nancy Thiry, et al.
Applied Health Economics and Health Policy|September 9, 2008
Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian contextMattias Neyt, Nancy Thiry, Dirk Ramaekers, et al.
Pharmacoeconomics|December 18, 2002
Economic evaluations of varicella vaccination programmes: a review of the literatureNancy Thiry, Philippe Beutels, Pierre Van Damme, et al.
International Journal of Technology Assessment in Health Care|October 17, 2007
Introduction of emerging medical devices on the market: a new procedure in BelgiumImgard Vinck, Mattias Neyt, Nancy Thiry, et al.
BMC Pulmonary Medicine|September 17, 2010
Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditionsMattias Neyt, Stephan Devriese, Nancy Thiry, et al.
Vaccine: X|October 23, 2023
Efficacy and safety of the recombinant zoster vaccine: A systematic review and meta-analysisRenate Zeevaert, Nancy Thiry, Charline Maertens de Noordhout, et al.
International Journal of Technology Assessment in Health Care|March 31, 2015
Belgian guidelines for economic evaluations: second editionNancy Thiry, Mattias Neyt, Stefaan Van De Sande, et al.
International Journal of Technology Assessment in Health Care|January 26, 2011
Using threshold values for cost per quality-adjusted life-year gained in healthcare decisionsIrina Cleemput, Mattias Neyt, Nancy Thiry, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|July 10, 2009
Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in BelgiumIrina Cleemput, Nancy Thiry
Vaccine|January 9, 2007
Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006)Philippe Beutels, Nancy Thiry, Pierre Van Damme
Health Policy (Amsterdam, Netherlands)|May 22, 2012
Calculating an intervention's (cost-)effectiveness for the real-world target population: the potential of combining strengths of both RCTs and observational dataMattias Neyt, Irina Cleemput, Nancy Thiry, et al.
Applied Health Economics and Health Policy|September 9, 2008
Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian contextMattias Neyt, Nancy Thiry, Dirk Ramaekers, et al.
Pharmacoeconomics|December 18, 2002
Economic evaluations of varicella vaccination programmes: a review of the literatureNancy Thiry, Philippe Beutels, Pierre Van Damme, et al.
International Journal of Technology Assessment in Health Care|October 17, 2007
Introduction of emerging medical devices on the market: a new procedure in BelgiumImgard Vinck, Mattias Neyt, Nancy Thiry, et al.
BMC Pulmonary Medicine|September 17, 2010
Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditionsMattias Neyt, Stephan Devriese, Nancy Thiry, et al.
Vaccine: X|October 23, 2023
Efficacy and safety of the recombinant zoster vaccine: A systematic review and meta-analysisRenate Zeevaert, Nancy Thiry, Charline Maertens de Noordhout, et al.
International Journal of Technology Assessment in Health Care|March 31, 2015
Belgian guidelines for economic evaluations: second editionNancy Thiry, Mattias Neyt, Stefaan Van De Sande, et al.
International Journal of Technology Assessment in Health Care|January 26, 2011
Using threshold values for cost per quality-adjusted life-year gained in healthcare decisionsIrina Cleemput, Mattias Neyt, Nancy Thiry, et al.
Pageof 3